Alzheimer Disease Clinical Trial
Official title:
Detecting Mild Cognitive Impairment and Probable Alzheimer's Disease From Speech Using Linguistic Deficits With Amyloid PET Imaging as a Baseline.
NCT number | NCT04041895 |
Other study ID # | 0218.16sw |
Secondary ID | |
Status | Withdrawn |
Phase | |
First received | |
Last updated | |
Start date | August 13, 2018 |
Est. completion date | August 2020 |
Verified date | November 2022 |
Source | East Tennessee State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The object of this study is to investigate the use of linguistic deficits from speech samples for the early detection of Mild Cognitive Impairment and probable Alzheimer's disease. It will also evaluate whether the result of the Amyloid PET scan would confirm the effectiveness of a less expensive and less intrusive diagnostic technique through speech
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | August 2020 |
Est. primary completion date | August 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Participants who have undergone the Mini Mental State Examination (MMSE). - Participants who have undergone Amyloid PET scan with a diagnosis of having the Amyloid plaques or not. - Participants with moderate or fluent English speaking ability. Exclusion Criteria: - Participants who cannot speak as the data collection process needs to obtain speech samples. - Participants who are severely demented or at a very late stage of Alzheimer's disease. - Participants with stroke. - Participants who report a history of other neurodegenerative disorders than MCI and AD. - Participants with chronic vision impairment or who cannot see with the aid of corrective glasses. - Participants who cannot speak English. - A participant who have been diagnosed with HIV/AIDS as this may have a cognitive effect on its own. |
Country | Name | City | State |
---|---|---|---|
United States | East Tennessee State University | Johnson City | Tennessee |
Lead Sponsor | Collaborator |
---|---|
East Tennessee State University |
United States,
10. Lunsford, R., & Heeman, P. A. (2015, September). Using linguistic indicators of difficulty to identify mild cognitive impairment. In INTERSPEECH (pp. 658-662).
Fraser KC, Meltzer JA, Graham NL, Leonard C, Hirst G, Black SE, Rochon E. Automated classification of primary progressive aphasia subtypes from narrative speech transcripts. Cortex. 2014 Jun;55:43-60. doi: 10.1016/j.cortex.2012.12.006. Epub 2012 Dec 21. — View Citation
Fraser KC, Meltzer JA, Rudzicz F. Linguistic Features Identify Alzheimer's Disease in Narrative Speech. J Alzheimers Dis. 2016;49(2):407-22. doi: 10.3233/JAD-150520. — View Citation
Klimova B, Maresova P, Valis M, Hort J, Kuca K. Alzheimer's disease and language impairments: social intervention and medical treatment. Clin Interv Aging. 2015 Aug 27;10:1401-7. doi: 10.2147/CIA.S89714. eCollection 2015. Review. — View Citation
Orimaye SO, Wong JS, Golden KJ, Wong CP, Soyiri IN. Predicting probable Alzheimer's disease using linguistic deficits and biomarkers. BMC Bioinformatics. 2017 Jan 14;18(1):34. doi: 10.1186/s12859-016-1456-0. — View Citation
Orimaye, S. O., Wong, J. S. M., & Golden, K. J. (2014, June). Learning predictive linguistic features for Alzheimer's disease and related dementias using verbal utterances. In Proceedings of the 1st Workshop on Computational Linguistics and Clinical Psychology (CLPsych) (pp. 78-87). sn.
Prud'hommeaux E, Roark B. Graph-Based Word Alignment for Clinical Language Evaluation. Comput Linguist Assoc Comput Linguist. 2015 Dec;41(4):549-578. doi: 10.1162/coli_a_00232. Epub 2015 Dec 1. — View Citation
Reilly J, Rodriguez AD, Lamy M, Neils-Strunjas J. Cognition, language, and clinical pathological features of non-Alzheimer's dementias: an overview. J Commun Disord. 2010 Sep-Oct;43(5):438-52. doi: 10.1016/j.jcomdis.2010.04.011. Epub 2010 May 6. Review. — View Citation
Roark B, Mitchell M, Hosom JP, Hollingshead K, Kaye J. Spoken Language Derived Measures for Detecting Mild Cognitive Impairment. IEEE Trans Audio Speech Lang Process. 2011 Sep 1;19(7):2081-2090. — View Citation
Verma M, Howard RJ. Semantic memory and language dysfunction in early Alzheimer's disease: a review. Int J Geriatr Psychiatry. 2012 Dec;27(12):1209-17. doi: 10.1002/gps.3766. Epub 2012 Feb 1. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Analysis of speech audio recording describing the "Cookie-Thief Image" using proposed computational model designed by PI for determination of Alzheimer's disease | Analysis of speech audio recording of participants description of Cookie-Thief Image The image is part of the Provide a brief but thorough description of the study. What is the study about? This does not need to contain a summary of background literature. It should just summarize the study itself. Boston Diagnostic Aphasia Examination (BDAE-3) and it is adapted in our study for the purpose of capturing the complexity in the linguistic expression similar to the DementiaBank project (https://talkbank.org/media/DementiaBank/Pitt/cookie/) using proposed computational model for determination of Alzheimer's disease | through study completion, an average of 1 year | |
Secondary | MMSE | Mini Mental State Examination | through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |